Search research articles
Contact Us
Filters
Showing results (411-420 of 535) with videos related to
Page
of 54
Sort By:
Oncogene
|
August 1, 1996
SV40-like sequences in human bone tumors
M Carbone, P Rizzo, A Procopio, et al.
The Journal of Clinical Investigation
|
November 8, 2016
MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
Cecilia Dallavalle, Domenico Albino, Gianluca Civenni, et al.
Clinical and Diagnostic Laboratory Immunology
|
September 3, 1999
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay
K Yamaguchi, T Sawada, T Naraki, et al.
Cancer Research
|
May 21, 2013
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression
Nicole Longoni, Manuela Sarti, Domenico Albino, et al.
Nature Communications
|
August 6, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer
Alessia Cacciatore, Dheeraj Shinde, Carola Musumeci, et al.
Oncogene
|
February 15, 2012
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression
F Babbio, C Pistore, L Curti, et al.
Nature Communications
|
July 7, 2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
Marita Zoma, Laura Curti, Dheeraj Shinde, et al.
Clinical and Experimental Immunology
|
February 12, 2016
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
F Bernuzzi, F Marabita, A Lleo, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy
Paola Manara, Austin D Newsam, Venu Vg Saralamma, et al.
Nature Communications
|
May 31, 2017
A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers
Giuseppina Pisignano, Sara Napoli, Marco Magistri, et al.
Page
of 54
Search research articles
Search
Showing results (411-420 of 535) with videos related to
Sort By:
Page
of 54
Oncogene
|
August 1, 1996
SV40-like sequences in human bone tumors
M Carbone, P Rizzo, A Procopio, et al.
The Journal of Clinical Investigation
|
November 8, 2016
MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
Cecilia Dallavalle, Domenico Albino, Gianluca Civenni, et al.
Clinical and Diagnostic Laboratory Immunology
|
September 3, 1999
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay
K Yamaguchi, T Sawada, T Naraki, et al.
Cancer Research
|
May 21, 2013
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression
Nicole Longoni, Manuela Sarti, Domenico Albino, et al.
Nature Communications
|
August 6, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer
Alessia Cacciatore, Dheeraj Shinde, Carola Musumeci, et al.
Oncogene
|
February 15, 2012
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression
F Babbio, C Pistore, L Curti, et al.
Nature Communications
|
July 7, 2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
Marita Zoma, Laura Curti, Dheeraj Shinde, et al.
Clinical and Experimental Immunology
|
February 12, 2016
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
F Bernuzzi, F Marabita, A Lleo, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy
Paola Manara, Austin D Newsam, Venu Vg Saralamma, et al.
Nature Communications
|
May 31, 2017
A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers
Giuseppina Pisignano, Sara Napoli, Marco Magistri, et al.
Page
of 54